Get the Stockscreener App
13.14
6.22%
0.77
After Hours:
13.14
Integra Lifesciences Holdings Corp stock is traded at $13.14, with a volume of 3.09M.
It is up +6.22% in the last 24 hours and up +7.09% over the past month.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
See More
Previous Close:
$12.37
Open:
$13.1
24h Volume:
3.09M
Relative Volume:
2.32
Market Cap:
$1.02B
Revenue:
$1.53B
Net Income/Loss:
$40.23M
P/E Ratio:
26.28
EPS:
0.5
Net Cash Flow:
$60.93M
1W Performance:
+3.38%
1M Performance:
+7.09%
6M Performance:
-49.66%
1Y Performance:
-47.04%
1-Day Range:
$12.99
$14.07
1-Week Range:
$12.27
$14.07
52-Week Range:
$11.06
$27.13
Integra Lifesciences Holdings Corp Stock (IART) Company Profile
Name
Integra Lifesciences Holdings Corp
Sector
Industry
Phone
(609) 275-0500
Address
1100 CAMPUS ROAD, PRINCETON, NJ
Compare IART with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IART
Integra Lifesciences Holdings Corp
|
13.14 | 961.30M | 1.53B | 40.23M | 60.93M | 0.50 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Dec-02-24 | Initiated | Morgan Stanley | Underweight |
| Oct-07-24 | Upgrade | BTIG Research | Sell → Neutral |
| Jul-30-24 | Downgrade | BTIG Research | Neutral → Sell |
| Jul-30-24 | Downgrade | Citigroup | Neutral → Sell |
| May-07-24 | Downgrade | Oppenheimer | Outperform → Perform |
| May-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-03-24 | Upgrade | Citigroup | Sell → Neutral |
| Dec-05-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-14-23 | Initiated | CL King | Buy |
| Aug-24-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jul-12-23 | Upgrade | Jefferies | Hold → Buy |
| Jun-08-23 | Downgrade | Argus | Buy → Hold |
| May-24-23 | Downgrade | JP Morgan | Neutral → Underweight |
| May-23-23 | Downgrade | Citigroup | Neutral → Sell |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-25-22 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Dec-17-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-15-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-08-20 | Downgrade | JP Morgan | Neutral → Underweight |
| May-27-20 | Initiated | Citigroup | Neutral |
| Apr-03-20 | Initiated | SunTrust | Buy |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-03-19 | Initiated | SunTrust | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-07-18 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jul-26-18 | Upgrade | BTIG Research | Neutral → Buy |
| Jul-02-18 | Downgrade | Citigroup | Buy → Neutral |
| Jan-05-18 | Resumed | Cantor Fitzgerald | Neutral |
| Jan-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Nov-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-30-17 | Downgrade | Wells Fargo | Outperform → Market Perform |
| Oct-27-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-30-17 | Initiated | Cantor Fitzgerald | Overweight |
| May-02-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-13-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jan-06-17 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Dec-12-16 | Initiated | UBS | Buy |
View All
Integra Lifesciences Holdings Corp Stock (IART) Latest News
How Integra LifeSciences Holdings Corporation stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Integra: Q2 Earnings Snapshot - CTPost
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations By Investing.com - Investing.com Canada
Earnings call transcript: Integra LifeSciences Q2 2025 beats EPS expectations - Investing.com
Integra Lifesciences Holdings Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Integra LifeSciences Q2 2025 slides: Revenue dips, projects second-half rebound - Investing.com Canada
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performanc - GuruFocus
Integra Lifesciences Holdings Corp Reports Q2 Revenue of $415.6M, Exceeding Estimates; Adjusted EPS at $0.45, Surpassing Expectations - GuruFocus
Integra Lifesciences Topped Revenue Estimates Despite Investor Caution - Finimize
Integra LifeSciences Reports Second Quarter 2025 Financial Results - TradingView
Integra LifeSciences (IART) Reports Strong Q2 Revenue Performance - GuruFocus
Integra Lifesciences Holdings Corp to Report Q2 2025 Earnings on July 31, 2025 with Expected Revenue of $395.07 Million and Earnings of $0.00 per Share - AInvest
Earnings To Watch: Integra Lifesciences Holdings Corp (IART) Reports Q2 2025 Result - Yahoo Finance
Allianz Asset Management GmbH Buys 71,939 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Integra LifeSciences (IART) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo.co
Published on: 2025-07-29 18:17:19 - metal.it
Cwm LLC Boosts Position in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Why Integra LifeSciences Holdings Corporation stock attracts strong analyst attentionFree Accurate Technical Trend Reversal Picks - Newser
Should I hold or sell Integra LifeSciences Holdings Corporation stock in 2025Discover breakthrough investment opportunities - jammulinksnews.com
What is Integra LifeSciences Holdings Corporation company’s growth strategyGet alerts on the hottest stocks daily - jammulinksnews.com
How Efficient Is Integra LifeSciences Holdings Corporation at Controlling Operating CostsFast Growing Stocks - Newser
Integra LifeSciences Holdings Corporation Company Revenue and Profit Trends: A Deep Dive - Newser
Strong week for Integra LifeSciences Holdings (NASDAQ:IART) shareholders doesn't alleviate pain of three-year loss - Yahoo Finance
Can Integra LifeSciences Holdings Corporation stock recover from recent declineOutperformance with explosive growth - jammulinksnews.com
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - uk.finance.yahoo.com
What analysts say about Integra LifeSciences Holdings Corporation stockConsistently exceptional gains - Autocar Professional
What drives Integra LifeSciences Holdings Corporation stock priceUnprecedented profits - jammulinksnews.com
Bank of New York Mellon Corp Trims Holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Teacher Retirement System of Texas Purchases New Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Is Integra LifeSciences Holdings Corporation a good long term investmentFree Popular Stock Recommendations - Autocar Professional
Integra Lifesciences Holdings Corp Stock Down 5.34% on July 18 Amid Analyst Forecast and GF Value Estimates - AInvest
Integra LifeSciences Holdings Corporation Stock Analysis and ForecastOutstanding stock performance - jammulinksnews.com
What makes Integra LifeSciences Holdings Corporation stock price move sharplyFree Stock Selection with 300% Return - Newser
Principal Financial Group Inc. Buys 10,492 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) - Defense World
Integra LifeSciences to Announce Second Quarter 2025 Financial Results on July 31 - Quiver Quantitative
Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025 - Yahoo Finance
Integra LifeSciences to Release Q2 2025 Earnings Pre-Market July 31How to Join the Call - Stock Titan
Integra Lifesciences Holdings Corp Shares Down 4.63% on Jul 11, Average Target Price at $16.71 - AInvest
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know - Yahoo Finance
11,425 Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World
Wound Care Centers Market Report 2025-2030, with Profiles of Smith & Nephew, 3M, Molnlycke Health Care, ConvaTec, Coloplast, Medline, Integra LifeSciences, B. Braun, Cardinal Health, & Derma Sciences - Yahoo.co
Integra LifeSciences Announces First Patient Enrollment in Acclarent AERA Pediatric Registry for Eustachian Tube Dysfunction in Children - Quiver Quantitative
Integra LifeSciences Enrolls First Patient in Pediatric Registry for Eustachian Tube Balloon Dilation System - MarketScreener
Judge Rejects Integra Investor's Suit Over Factory Issues - Law360
Integra Earns Win in Investor Lawsuit Over FDA Warning Response - Bloomberg Law News
Integra LifeSciences Holdings Corporation(NasdaqGS:IART) dropped from Russell 2000 Value-Defensive Index - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings CorporationIART - PR Newswire
Closing Figures Unveiled: Integra Lifesciences Holdings Corp (IART) Gain 1.89, Closes at 12.39 - DWinneX
Handelsbanken Fonder AB Raises Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World
Integra LifeSciences Holdings Co. (NASDAQ:IART) Stock Position Reduced by Rhumbline Advisers - Defense World
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):